Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$421,559,918
New position
Shares Held
2,137,511
first reported quarter
Ownership
0.138%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 3.873336792184929.ToString("F0")%
None 96.12666320781507.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NATIONAL BANK OF CANADA /FI/ holds $2,581,293,363 across 17 Drug Manufacturers - General names. AZN ranks #3 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
620,178 | $570,421,117 | |
| 2 | JNJ |
Johnson & Johnson
|
1,731,044 | $423,136,394 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
2,137,511 | $421,559,918 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,961,390 | $235,935,600 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,614,500 | $225,012,862 | |
| 6 | ABBV |
AbbVie Inc.
|
927,136 | $201,642,805 | |
| 7 | AMGN |
Amgen Inc
|
420,993 | $148,126,385 | |
| 8 | PFE |
Pfizer Inc
|
5,136,267 | $144,226,376 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $421,559,918 | 2,137,511 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||